CollPlant Biotechnologies Ltd (CLGN)
↓ Download CSV- Sector Manufacturing
- Incorporated L3
- Fiscal year ends Dec 31
In fiscal 2025, CollPlant Biotechnologies Ltd reported revenue of $2.37M, up 360.4% from the prior year. The company ran a net loss, with a net margin of -484.6% and a gross margin of 64.8%. It held $10.79M in total assets against $4.70M in total liabilities.
Key ratios (FY2025)
64.8%
Gross margin
-484.3%
Operating margin
-484.6%
Net margin
-188.9%
Return on equity
+360.4%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.37M | $515.0K | $10.96M | $299.0K | $15.64M | $6.14M | $2.32M | $5.01M | — |
| Cost of Revenue | $835.0K | $1.62M | $1.99M | $400.0K | $2.00M | $3.00M | $1.88M | $1.66M | — |
| Gross Profit | $1.54M | -$1.11M | $8.97M | -$101.0K | $13.64M | $3.13M | $439.0K | $3.35M | — |
| Operating Income | -$11.48M | -$17.25M | -$7.51M | -$17.10M | $65.0K | -$5.60M | -$7.63M | -$4.25M | — |
| Net Income | -$11.49M | -$16.61M | -$7.02M | -$16.93M | $237.0K | -$5.77M | -$11.16M | -$6.25M | — |
| EPS (Diluted) | $-0.94 | $-1.45 | $-0.62 | $-1.53 | $0.02 | $-0.84 | $-2.23 | — | — |
| Total Assets | $10.79M | $18.71M | $34.13M | $37.77M | $51.22M | $10.84M | $10.75M | — | — |
| Total Liabilities | $4.70M | $5.25M | $5.79M | $5.49M | $6.10M | $6.36M | $6.66M | — | — |
| Shareholders' Equity | $6.08M | $13.46M | $28.34M | $32.28M | $45.12M | $4.48M | $4.09M | $5.42M | $5.17M |
| Cash & Equivalents | $5.59M | $11.91M | $26.67M | $29.65M | $13.15M | $3.33M | $3.79M | $5.35M | — |
| Operating Cash Flow | -$9.42M | -$14.09M | -$2.76M | -$13.70M | $2.50M | -$4.45M | -$5.70M | -$1.22M | — |
| Capital Expenditures | $28.0K | $483.0K | $954.0K | $1.27M | $1.43M | $437.0K | $1.49M | $832.0K | — |
| Shares Outstanding | 12.80M | 11.45M | 11.45M | 11.19M | 10.77M | 6.96M | 5.67M | — | — |